William Blair & Company & JPMorgan Chase
10 shared events · Importance 3 · Last updated Jun 04, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Regulatory
William Blair & Company: William Blair also downgraded LegalZoom, citing search-channel uncertainty. This added to the negative analyst sentiment and downward pressure on the stock.
JPMorgan Chase: JPMorgan downgraded LegalZoom following the guidance cut, reflecting reduced growth visibility. This action contributed to negative market sentiment toward LegalZoom.
Aug 10, 2026 · 7 articles
Business
William Blair & Company: William Blair & Company acted as the lead manager for Kailera Therapeutics's IPO, facilitating the offering and earning underwriting fees.
JPMorgan Chase: JPMorgan Chase acted as a joint book-running manager for Kailera Therapeutics's IPO, facilitating the offering and earning underwriting fees.
Apr 16, 2026 · 8 articles
Business
William Blair & Company: William Blair & Company is acting as a bookrunner for the offering, participating in the distribution of shares.
JPMorgan Chase: JPMorgan Chase is acting as a bookrunning manager for the offering, supporting the lead managers in the distribution of shares.
Jun 01, 2026 · 8 articles
Business
William Blair & Company: William Blair is acting as an additional book-running manager for the proposed secondary offering of Pattern Group Inc. shares.
JPMorgan Chase: JPMorgan Chase is acting as a lead book-running manager for the proposed secondary offering of Pattern Group Inc. shares.
Jun 15, 2026 · 6 articles
Business
William Blair & Company: William Blair acted as additional bookrunning manager, earning underwriting fees.
JPMorgan Chase: J.P. Morgan acted as joint lead bookrunning manager, earning underwriting fees and enhancing its IPO advisory reputation.
Jul 20, 2026 · 19 articles
Tech
William Blair & Company: William Blair analyst Myles Minter said the results position both companies well for regulatory approval.
JPMorgan Chase: JPMorgan Chase analysts noted the launch of Intismeran will be key to Moderna's profitability, reflecting financial market interest.
Aug 19, 2026 · 108 articles
Business
William Blair & Company: Analyst firm; Andrew Jeffrey provided commentary on bid price.
JPMorgan Chase: Lead bank providing financing for the bid; committed $50 billion in debt.
Jul 15, 2026 · 96 articles
Business
William Blair & Company: William Blair & Company is one of the 16 banks participating in smaller roles for the SpaceX IPO.
Mar 27, 2026 · 61 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how William Blair & Company and JPMorgan Chase interact across events, view sentiment trends, and discover connected entities.
Open Dashboard